GlassScriptPhysician profile
Simeon A Lauer
NPI 1790894723
$5,969.27
in general payments reported to CMS, 2019-2025
10 companies · $230 in 2025
The $230 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.47 · 2020: $14.04 · 2021: $3,260 · 2022: $1,649 · 2023: $371 · 2024: $350 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $3,595.00 | 2019-2023 | Tepezza |
| Lensar, INC. | $1,243.65 | 2021 | |
| Sight Sciences, INC. | $274.65 | 2023-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $269.69 | 2024-2025 | Rocklatan, Clareon Panoptix Pro |
| Oyster Point Pharma, INC. | $255.36 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $146.56 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $79.06 | 2019 | |
| Apellis Pharmaceuticals, INC. | $67.08 | 2023 | Syfovre |
| Tarsus Pharmaceuticals, INC. | $25.02 | 2024 | Xdemvy |
| Amgen INC. | $13.20 | 2024 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simeon Lauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.